Incessant atrial tachycardias in a dog with tricuspid dysplasia. Clinical management and electrophysiology.
In a dog, tricuspid regurgitation due to congenital tricuspid dysplasia resulted in extreme right heart enlargement and right heart failure. Incessant supraventricular tachycardias were present, requiring the intravenous administration of verapamil to reduce the ventricular rate. Oral therapy using a combination of verapamil and quinidine was partially effective in controlling the ventricular rate during the following week. At that time, electrophysiologic studies were performed. They revealed that a succession of several atrial tachycardias with different cycle lengths, including one episode of atrial flutter, was present. Atrial activity was spanning the majority of the cycle length in all these arrhythmias. Epicardial mapping was performed during the atrial flutter. This enabled the detection of a depolarization wave-front traveling counterclockwise from the dorsolateral right atrium toward the right appendage, following the tricuspid valve annulus. No areas of abnormal conduction were detected. Because programmed electric stimulation maneuvers could not be performed, definitive conclusions about the mechanism of the arrhythmia could not be drawn. The two most likely possibilities were circus movement using part of the dilated tricuspid valve annulus as an anatomic barrier or a leading circle type of re-entry.
D000818:Animals; D004283:Dog Diseases / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D004285:Dogs; D004562:Electrocardiography; D008297:Male; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology / Q000662:veterinary*; D014261:Tricuspid Valve / Q000002:abnormalities* / Q000473:pathology; D014262:Tricuspid Valve Insufficiency / Q000151:congenital / Q000662:veterinary; D014700:Verapamil / Q000627:therapeutic use
D014700:Verapamil; D011802:Quinidine